Clinical Trials Directory

Trials / Completed

CompletedNCT01733810

The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Dallas VA Medical Center · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the role of hypoxia inducible factor (HIF)-2a on the production of inflammatory cytokines that lead to reflux esophagitis.

Detailed description

Reflux esophagitis is thought to be caused by gastric acid that refluxes into the esophagus, causing injury. Newer data suggest that reflux of gastric juice into the esophagus stimulates HIF-2a, which increases production of inflammatory cytokines. These cytokines are thought to lead to reflux esophagitis. The investigators plan to study the relationship of HIF-2a to inflammatory cytokines in patients with known gastroesophageal reflux disease and reflux esophagitis.

Conditions

Interventions

TypeNameDescription
OTHERCessation of Acid Suppressing MedicationsAcid-suppressing medications are stopped for all participants the day after baseline assessment. Subsequent evaluations performed while participant is not on acid-suppressing medications.

Timeline

Start date
2013-02-01
Primary completion
2015-07-31
Completion
2019-07-31
First posted
2012-11-27
Last updated
2020-02-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01733810. Inclusion in this directory is not an endorsement.